Lya_Cattel/iStock Unreleased via Getty Images Shares of CVS Health ( NYSE: CVS ) ended higher on Thursday, recording gains for its seven consecutive sessions and gaining over 13% over that period. The healthcare services company rose 0.46% to end the Thursday trading session at $60.
98. Since the start of the year, CVS Health has fallen about 23%, underperforming the broader S&P index. Looking at Seeking Alpha's Quant ratings, CVS had a Hold rating with a score of 3.
20 out of 5. The company received an A+ for profitability and a D- for its growth prospects. The stock got an A for valuation.
Turning to the Wall Street community, about 15 sell-side analysts surveyed in the last 90 days rated CVS as a Buy or higher. Meanwhile, another 13 analysts rated the company as a Hold or lower. Seeking Alpha analysts generally saw the company as a Buy.
The Insiders Forum , SA analyst, endorsed the company as a Hold, commenting that the company is facing higher medical benefit ratios in its Medicare Advantage plans and is ineligible for full-level quality bonuses in FY24. More on CVS Health The Correct Play On CVS Health CVS: Shares Decimated, But I'm Buying For The 4.6% Yield And Rebound Potential CVS Health Corporation (CVS) Bernstein's 40th Annual Strategic Decisions Conference CVS faces unionization in home state as pharmacists join new union CVS Health reportedly seeking investor to fund Oak Street expansion.
